Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $17,159 | 7 | 83.7% |
| Food and Beverage | $3,008 | 160 | 14.7% |
| Education | $340.32 | 13 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $17,385 | 20 | $0 (2022) |
| Myriad Genetic Laboratories, Inc. | $556.67 | 25 | $0 (2024) |
| Coloplast Corp | $502.59 | 18 | $0 (2022) |
| Janssen Biotech, Inc. | $330.47 | 22 | $0 (2020) |
| Astellas Pharma US Inc | $173.80 | 7 | $0 (2023) |
| AbbVie Inc. | $156.63 | 12 | $0 (2023) |
| Boston Scientific Corporation | $135.88 | 6 | $0 (2022) |
| C. R. Bard, Inc. & Subsidiaries | $126.58 | 3 | $0 (2020) |
| Endo Pharmaceuticals Inc. | $120.94 | 6 | $0 (2022) |
| Olympus America Inc. | $116.97 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $208.53 | 10 | Myriad Genetic Laboratories, Inc. ($139.51) |
| 2023 | $487.84 | 22 | Myriad Genetic Laboratories, Inc. ($191.83) |
| 2022 | $531.22 | 29 | Myriad Genetic Laboratories, Inc. ($118.40) |
| 2021 | $371.64 | 18 | COLOPLAST CORP ($127.60) |
| 2020 | $557.69 | 25 | Coloplast Corp ($111.27) |
| 2019 | $17,644 | 31 | Allergan Inc. ($17,212) |
| 2018 | $451.24 | 27 | Janssen Biotech, Inc. ($125.11) |
| 2017 | $255.63 | 18 | AbbVie, Inc. ($89.83) |
All Payment Transactions
180 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: ONCOLOGY | ||||||
| 11/26/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $16.15 | General |
| Category: Prostate cancer | ||||||
| 09/24/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: ONCOLOGY | ||||||
| 05/28/2024 | BIOPROTECT MEDICAL, INC. | BIOPROTECT BALLOON IMPLANT SYSTEM (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Rectal Spacers Used in Prostate Cancer Radiation Therapy | ||||||
| 02/22/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $24.45 | General |
| Category: ONCOLOGY | ||||||
| 02/20/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Urology | ||||||
| 12/12/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $96.51 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: ONCOLOGY | ||||||
| 10/26/2023 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Urology | ||||||
| 10/17/2023 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: ONCOLOGY | ||||||
| 09/14/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $12.73 | General |
| Category: Prostate cancer | ||||||
| 09/07/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/05/2023 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/25/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Oncology | ||||||
| 08/23/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Prostate cancer | ||||||
| 08/22/2023 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2023 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: OS | ||||||
| 05/26/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Urology | ||||||
| 04/20/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Urology | ||||||
| 04/17/2023 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,387 | 8,765 | $695,439 | $267,737 |
| 2022 | 27 | 3,383 | 11,559 | $718,494 | $271,957 |
| 2021 | 28 | 3,246 | 7,702 | $702,443 | $270,113 |
| 2020 | 26 | 2,846 | 8,444 | $624,215 | $221,194 |
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 695 | 1,228 | $196,480 | $111,924 | 57.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 498 | 673 | $67,300 | $42,428 | 63.0% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 29 | 198 | $138,550 | $26,898 | 19.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 84 | 127 | $50,800 | $23,283 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $26,765 | $11,446 | 42.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 18 | 20 | $24,000 | $6,198 | 25.8% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 19 | 19 | $9,120 | $4,636 | 50.8% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 23 | 23 | $19,550 | $4,609 | 23.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 826 | 1,332 | $13,320 | $4,513 | 33.9% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 14 | 67 | $20,100 | $4,334 | 21.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 46 | 46 | $8,280 | $3,524 | 42.6% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 117 | 143 | $27,742 | $3,327 | 12.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 107 | 139 | $8,340 | $2,972 | 35.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 260 | 367 | $12,845 | $2,789 | 21.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 171 | 240 | $36,000 | $2,459 | 6.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 14 | 14 | $6,090 | $2,435 | 40.0% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 25 | 26 | $11,180 | $2,010 | 18.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 29 | 61 | $4,270 | $1,584 | 37.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 39 | 88 | $3,520 | $1,500 | 42.6% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 14 | $3,668 | $1,489 | 40.6% |
| 86386 | Protein test for diagnosis and monitoring of bladder cancer | Office | 2023 | 55 | 60 | $3,000 | $1,280 | 42.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 121 | 133 | $1,064 | $1,043 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $770.00 | $449.10 | 58.3% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 36 | 3,600 | $2,160 | $434.25 | 20.1% |
| 82565 | Blood creatinine level | Office | 2023 | 35 | 35 | $525.00 | $175.70 | 33.5% |
About Dr. Stephen Baker, MD
Dr. Stephen Baker, MD is a Urology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1528056785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Baker, MD has received a total of $20,508 in payments from pharmaceutical and medical device companies, with $208.53 received in 2024. These payments were reported across 180 transactions from 48 companies. The most common payment nature is "Gift" ($17,159).
As a Medicare-enrolled provider, Baker has provided services to 12,862 Medicare beneficiaries, totaling 36,470 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Orlando, FL
- Active Since 10/12/2005
- Last Updated 07/19/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1528056785
Products in Payments
- NATRELLE (Device) $17,159
- MYRISK (Device) $253.25
- Erleada (Drug) $244.65
- SpeediCath (Device) $200.57
- BOTOX (Biological) $200.54
- SPEEDICATH (Device) $179.11
- Prolaris (Device) $170.81
- XIAFLEX (Biological) $120.94
- Myrbetriq (Drug) $118.80
- Androgel (Drug) $101.85
- CONTINENCE CARE (Device) $100.46
- PROLARIS (Device) $78.09
- UGN Laser Capital (Device) $69.11
- BOTOX THERAPEUTIC (Biological) $68.15
- ERLEADA (Drug) $68.12
- ELIGARD (Drug) $60.59
- BIOFIX (Device) $56.01
- BRAC CDx (Device) $54.52
- PLUVICTO (Drug) $53.49
- ENDOBEAM (Device) $50.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Orlando
Dr. Olubayo Tojuola, M.d, M.D
Urology — Payments: $213,572
Jeffrey Brady, M.d, M.D
Urology — Payments: $135,720
Dr. Lucas Wiegand, Md, MD
Urology — Payments: $103,853
Albert Ong, M.d, M.D
Urology — Payments: $86,166
Christopher Russell, Md, MD
Urology — Payments: $24,045
Dr. Benjamin Rhee, M.d, M.D
Urology — Payments: $20,210